Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Cline Scientific

Less than 1K followers
All
Press releases
ShowingAll content types

Regulatory press release12.08.2024 klo 12.34

Cline Scientific's bankruptcy application granted

Cline Scientific
Regulatory press release12.08.2024 klo 09.29

Cline files for bankruptcy

Cline Scientific
Regulatory press release18.06.2024 klo 20.00

Cline Scientific: Communiqué from the Annual General Meeting

Cline Scientific

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release26.05.2024 klo 10.15

Annual Report for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023

Cline Scientific
Regulatory press release16.05.2024 klo 09.30

Notice to the Annual General Meeting of Cline Scientific AB

Cline Scientific
Regulatory press release30.04.2024 klo 11.05

Cline Scientific provides an update on the company's financial position

Cline Scientific
Press release15.03.2024 klo 09.45

BioStock: Scientific Advisor on the potential of Cline's cell therapy for cartilage damage

Cline Scientific
Press release01.03.2024 klo 09.30

Cline: StemCART updates on achieved milestones on the way to phase 1 study

Cline Scientific
Regulatory press release23.02.2024 klo 09.30

Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2023

Cline Scientific
Press release13.02.2024 klo 09.30

Cline Scientific advisor discusses the future of cartilage damage treatment

Cline Scientific
Regulatory press release18.01.2024 klo 21.12

Cline Scientific provides an update on the company's financial position

Cline Scientific
Press release18.01.2024 klo 20.15

Cline Scientific provides an update on the company's financial position

Cline Scientific
Press release11.01.2024 klo 20.57

Information regarding trade in Clines share, CLINE B

Cline Scientific
Press release22.12.2023 klo 13.13

Cline: Medtech4Health supports capacity building in the strategy and regulatory pathway for StemCART

Cline Scientific
Press release14.12.2023 klo 09.45

BioStock: Cline's CEO: "Gotten a long way with small means"

Cline Scientific
Press release08.12.2023 klo 13.00

CORRECTION: Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future

Cline Scientific
Press release07.12.2023 klo 14.03

Newsletter December 2023 - Summing up the year with a Christmas message and Cline's bright view of the future

Cline Scientific
Press release21.11.2023 klo 14.33

BioStock: Cline Scientific's CEO convicted of market manipulation

Cline Scientific
Press release21.11.2023 klo 12.18

Judgment in the market manipulation case against Cline Scientific's CEO Patrik Sundh

Cline Scientific
Press release30.10.2023 klo 10.38

BioStock: Cline aims for stem cell breakthrough with nanotechnology

Cline Scientific